Labcorp (LH) Tops Q3 EPS by 1c; Offers FY22 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Labcorp Announces 2022 Third Quarter Results
October 27, 2022 7:00 AM EDTCompany Updates Full-Year GuidanceÂ
Revenue: Q3 of $3.6 billion versus $4.1 billion last year Diluted EPS: Q3 of $3.90 versus $6.05 last year Adjusted EPS: Q3 of $4.68 versus $6.82 last year Free Cash Flow: Q3 of $270 million versus $650 million last year Progressed Clinical Development business spin-off activities Completed transactions to establish long-term relationship with AscensionÂ
BURLINGTON, N.C.--(BUSINESS WIRE)-- Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the third quarter ended Sept. 30, 2022, and updated full-year... More
